Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | PRKCA | P17252 | 1/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27469007 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL31379960 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL32678345 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL769294 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL32678347 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL32678346 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL3930992 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL3028731 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL3720851 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA | |
| SCHEMBL545424 | 1.00 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4554551-B1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2026-03-11 | — | — | EP | claimed |
| EP-4203902-B1 | HAIR CARE COMPOSITION WITH A ANTIDANDRUFF EFFECT | HENKEL AG & CO KGAA (DE) | 2026-03-11 | — | — | EP | claimed |
| WO-2026041513-A1 | POLYGLYCEROL PARTIAL ESTERS OF SHORT-CHAIN CARBOXYLIC ACIDS | EVONIK OPERATIONS GMBH (DE) | 2026-02-26 | — | — | WO | claimed |
| EP-4618942-A1 | ANTIMICROBIAL PREPARATION COMPRISING A POLYLYSINE AND PROPANEDIOL CAPRYLATE | Beiersdorf AG (DE) | 2025-09-24 | — | — | EP | claimed |
| EP-4103288-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION | SYMRISE AG (DE) | 2025-07-30 | — | — | EP | claimed |
| WO-2025132038-A2 | COSMETIC COMPOSITION COMPRISING A SYNERGISTIC ANTIMICROBIAL COMPLEX | LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER (FR) | 2025-06-26 | — | — | WO | claimed |
| EP-4565334-A1 | SKIN AND HAIR CARE FORMULATIONS | Clarity Cosmetics Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| EP-4554551-A1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | Symrise AG (DE) | 2025-05-21 | — | — | EP | claimed |
| US-20250107979-A1 | Hair Treatment Compositions Having Anti-Dandruff Action | HENKEL AG & CO. KGAA (DE) | 2025-04-03 | — | — | US | claimed |
| EP-4203902-A1 | HAIR TREATMENT COMPOSITIONS HAVING ANTIDANDRUFF ACTION | Henkel AG & Co. KGaA (DE) | 2023-07-05 | — | — | EP | claimed |
| EP-4190307-A1 | LEAVE-ON COSMETIC PRODUCTS FOR IMPROVING STYLING PROPERTIES | Henkel AG & Co. KGaA (DE) | 2023-06-07 | — | — | EP | claimed |
| US-20220257485-A1 | PREBIOTIC COSMETIC COMPOSITIONS AND METHODS FOR THE PREPARATION THEREOF | COSTE, Fanny (GB) | 2022-08-18 | — | — | US | claimed |
| EP-3993759-A2 | PREBIOTIC COSMETIC COMPOSITIONS AND METHODS FOR THE PREPARATION THEREOF | Cosmevia LLC (US) | 2022-05-11 | — | — | EP | claimed |
| US-20220117867-A1 | ANTIMICROBIAL ACTIVITY OF FATTY ACID ESTERS AND COMBINATIONS THEREOF | SYMRISE AG (DE) | 2022-04-21 | — | — | US | claimed |
| WO-2022042979-A1 | HAIR TREATMENT COMPOSITIONS HAVING ANTIDANDRUFF ACTION | HENKEL AG & CO. KGAA (DE) | 2022-03-03 | — | — | WO | claimed |
| WO-2021007091-A2 | PREBIOTIC COSMETIC COMPOSITIONS AND METHODS FOR THE PREPARATION THEREOF | COSMEVIA LLC (US) | 2021-01-14 | — | — | WO | claimed |
| US-10108102-B2 | Fixing solution and image forming method | Konica Minolta, Inc. (JP) | 2018-10-23 | — | — | US | claimed |
| US-20130259550-A1 | FIXING SOLUTION AND IMAGE FORMING METHOD | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2013-10-03 | — | — | US | claimed |
| EP-0359087-A2 | Proteolytic perhydrolysis system and method of use for bleaching | The Clorox Company (US) | 1990-03-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250107979-A1 | Hair Treatment Compositions Having Anti-Dandruff Action | POLR1C, HSD3B1, PIK3C3 | LMNA 1845/4885MAPT 3228/4885MAPK1 1492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.